ArticleBMC cancer2024
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Abstract readPublished Erratum
In one paragraph
Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer.Cancer medicine · 2026Article
- Current insights and future perspectives of treatment strategies for biliary tract cancer.World journal of gastrointestinal oncology · 2025Review
Corrections and comments
- Erratum for
Authors and funding
37 authors.
Monica NigerDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy. Monica.niger@istitutotumori.mi.it.
Federico NichettiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Lorenzo FornaroMedical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Chiara PircherDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Federica MoranoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Federica PalermoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Lorenza RimassaDepartment of Biomedical Sciences, Pieve Emanuele (Milan), Humanitas University, Milan, Italy.
Tiziana PressianiMedical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Rossana BerardiClinica Di Oncologia Medica, A.O.U. Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.
Andrea Casadei GardiniVita-Salute San Rafaele University, Milan, Italy.
Elisa SpertiDepartment of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy.
Lisa SalvatoreOncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 11Oncologia Medica, Rome, Italy.
Davide MelisiMolecular Clinical Oncology Research Unit, Università Degli Studi Di Verona, Verona, Italy.
Francesca BergamoMedical Oncology 1 Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Salvatore SienaDepartment of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Stefania MosconiMedical Oncology Unit, Giovanni XXIII Hospital, Bergamo, Italy.
Rafaella LongariniSan Gerardo Hospital, Monza, Italy.
Giuseppina ArcangeliDepartment of Medical Oncology, ASST Spedali Civili, Brescia, Italy.
Salvatore CoralloMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Laura DellipontiMedical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Stefano TamberiDepartment of Medical Oncology, Ospedale Santa Maria Delle Croci, Ravenna AUSL Romagna, Ravenna, Italy.
Elena FeaDepartment of Medical Oncology, S. Croce E Carle Teaching Hospital, Cuneo, Italy.
Giovanni BrandiMedical Oncology, IRCCS Azienda Ospedaliera, Universitaria Di Bologna, Bologna, Italy.
Ilario Giovanni RapposelliDepartment of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Massimiliano SalatiOncology Unit, University Hospital of Modena, Modena Cancer Centre, Modena, Italy.
Paolo BailiDepartment of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Rosalba MiceliBiostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Silva LjevarBiostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ilaria CavalloScientifc Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Elisa SottotettiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Antonia MartinettiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Michele Droz Dit BussetDepartment of Surgery, Division of HPB, General Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Carlo SpositoDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Maria Di BartolomeoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Filippo PietrantonioDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Filippo de BraudDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
Vincenzo MazzaferroDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.